CERA

Partner with us

Partnerships

We welcome funders, industry partners and other investors to join us on our mission to transform the future of eye health and vision.

The Centre for Eye Research Australia offers a unique combination of infrastructure, capabilities and capacity to take translational research from the bench through to patients – both at the bedside and in early intervention trials – to prevent eye disease.

We’re home to wide variety or research programs and start-up companies working towards solving the biggest challenges in eye disease using emerging technologies that have the capability to transform outcomes for patients.

Partners who invest with CERA help accelerate that pipeline – supporting research that is designed to move quickly and responsibly while generating measurable patient and societal benefit.

IP Asset pipeline

Project summaries


Eye drop activated gene therapy

SwitchGene

Platform anti-VEGF therapy able to selectively boost anti-VEGF expression with a topical eye drop.

RNA base editor

RNA base editing for Usher syndrome treatment

Novel RNA editing platform able to efficiently correct G>A mutations with high specificity.

(Re)programming cells to restore health

Mirugen

Mirugen is developing a treatment which harnesses the regenerative power of the retina’s own stem cells to prevent and reverse damage to the light sensing photoreceptors in the back of the eye.

Retinal gene delivery

Enhancing retinal infectivity of intravitreal AAV delivery via electrical stimulation

An all-in-one delivery device which can provide electrical stimulation alongside gene therapy delivery thereby improving the efficacy of intravitreal gene therapy.

Retinal hyperspectral imaging

Enlighten Imaging

Enlighten Imaging are pioneers in the field of retinal hyperspectral imaging, revolutionising the way we detect and diagnose eye, brain and systemic diseases.

Patient education

OneRightEye

Interactive 3D eye models that transform patient education in eye healthcare through immersive visualisation of disease progression and treatment options.

AI camera

Artificial intelligence powered diabetes complications screening tool using retinal imaging

Retinal imaging is a unique window to visualise systemic vascular changes, providing a simple, fast and non-invasive screening system for multiple diabetes complications.

For partnership opportunities, contact Shereen Tan: stan@cera.org.au
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.